Financials

  • Market Capitalization 79.68 M
  • Employee 13
  • Founded 2018
  • CEO N/A
  • Website www.maiabiotech.com
  • Headquarter Delaware, United States
  • FIGI BBG0113Q7J88
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
4036
TELO
Telomir Pharmaceuticals, Inc. - Common Stock
1.16 USD-0.85%+4.50%-2.52%-6.45%79.78 M USD
4037
MNOV
MediciNova, Inc. - Common Stock
1.62 USD0.00%+13.29%+18.25%+23.66%79.74 M USD
4048
GANX
Gain Therapeutics, Inc. - Common Stock
1.80 USD-1.10%+1.69%+1.12%+1.69%78.56 M USD
4060
RNTX
Rein Therapeutics, Inc. - Common Stock
0.89 USD+5.95%+15.58%+23.61%-19.11%76.78 M USD

MAIA Biotechnology, Inc. Common Stock

MAIA Biotechnology, Inc. 是一家总部位于伊利诺伊州芝加哥的上市免疫肿瘤学公司,专注于开发针对端粒的药物,用于治疗端粒酶阳性癌细胞。

新闻